SPL 2.00% 9.8¢ starpharma holdings limited

it obviously the study is not suitable for TGA approval. Didn’t...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 321 Posts.
    lightbulb Created with Sketch. 84
    it obviously the study is not suitable for TGA approval. Didn’t u read the announcement? Says it for change of EMDR riules from 2029.

    “The results from this study provide significant clinical evidence of the performance of Viraleze™ inhumans that will support regulatory processes for the transition to the new European Medical DeviceRegulations (MDR), which will come into full effect in 2029. The positive data will also support ongoingmarketing and commercial activities for the product.”
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.